menu

Medical Industry Feature: Best Practices for Curative-Intent Concurrent Chemoradiation Therapy in Unresectable Stage III NSCLC

Be part of the knowledge.
Register

We’re glad to see you’re enjoying ReachMD…
but how about a more personalized experience?

Register for free

Best Practices for Curative-Intent Concurrent Chemoradiation Therapy in Unresectable Stage III NSCLC

Program Information

Best Practices for Curative-Intent Concurrent Chemoradiation Therapy in Unresectable Stage III NSCLC
RestartResume

What are the best practices for curative-intent concurrent CRT for unresectable Stage III NSCLC? A radiation oncologist shares her experiences.

  • Sponsored by

  • Overview

    Concurrent chemoradiation therapy is the recommended treatment for unresectable Stage III NSCLC patients. Dr. Jennifer Caudle is joined by Dr. Kristin Higgins to discuss advances in radiation that optimize the treatment plan and her best practices to help patients receive a full course of curative-intent treatment.

    US-32345 Last Updated 12/19 

Facebook Comments

LIVE ON REACHMD RADIOBack to live radio

Loading...

Programs 12/3/20